
UK late-stage biopharma firm Immodulon Therapeutics has made two new senior appointments to its board of directors. Investment fund manager …
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time

